IDEX Corporation announced today the appointment of Mark A. Beck to the company’s Board of Directors, effective January 1, 2018.
“We are thrilled to welcome Mark to our Board of Directors,” said IDEX Chairman and Chief Executive Officer Andrew Silvernail. “His experience as a chief executive officer of a public company with significant international operations and his track record of innovation and successfully integrating acquired businesses will be a tremendous asset to IDEX. Mark is a values-based, results-oriented leader, making him a great fit with our Board and management.”
Beck has served as President and Chief Executive Officer of JELD-WEN Holding, Inc. (“JELD-WEN”), one of the world’s largest door and window manufacturers, since November 2015, and was appointed as a Director of JELD-WEN in May 2016. He joined JELD-WEN from Danaher Corporation, where he served as Executive Vice President, leading Danaher’s Water Quality and Dental platforms, beginning in April 2014. Previously, he spent 18 years with Corning Incorporated in a series of management positions with increasing responsibility, culminating in his appointment as Executive Vice President overseeing Corning’s Environmental Technologies and Life Science units in July 2012. He also served on the board of directors of Dow-Corning Corporation from 2010 to 2014. Beck holds a B.A. in Business Management from Pacific University and an M.B.A. from Harvard Business School.
The Food and Drug Administration’s top scientist Namandjé Bumpus will assume the role of principal deputy commissioner when longtime agency leader Janet Woodcock retires from that role in early 2024, according to an announcement Thursday.
US biopharma AbbVie has agreed to acquire ImmunoGen in a deal which values the company at about $10.1 billion and gives AbbVie access to flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved for platinum-resistant ovarian cancer (PROC), as well as a pipeline of promising next-generation ADCs.
EUROAPI today announced the appointment of David Seignolle as Chief Operating Officer, succeeding Eric Berger, and Marion Santin as Chief Legal, Compliance, and IP Officer, both joining the company’s Executive Committee. In his new role, David Seignolle will lead the transformation of the Industrial Operations organization.